AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting Notified -
Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy Notified -
Minimum Deposit Casinos Warns of Sweeping Changes as States Crack Down on Online Sweepstakes Casinos Notified -